Weston, Connecticut
United States
95
2023-05-18
The entities that hold a legal rights for patent applications filed by inventor During Matthew:
Matthew During from Weston, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Methods of treating seizure disorders and Prader-Willi syndrome
#2 | 2022-08-04USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS
#3 | 2022-01-20METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
#4 | 2021-12-09TREATMENT OF DEPRESSIVE DISORDERS
#5 | 2021-12-02RECOMBINANT ADENO-ASSOCIATED VECTORS
#6 | 2021-09-16METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#7 | 2021-07-15METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#8 | 2021-06-24Gaboxadol for therapeutic treatment of 1p36 deletion syndrome
#9 | 2021-06-17USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDERS AND ASTHMA
#10 | 2021-04-08Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
#11 | 2021-04-01Use of MIR101 or MIR128 in the treatment of seizure disorders
#12 | 2021-02-04Use of gaboxadol in the treatment of diabetes and related conditions
#13 | 2021-02-04METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#14 | 2021-01-21PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT
#15 | 2021-01-07Methods and compositions for treatment of epileptic disorders
#16 | 2020-12-03Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
#17 | 2020-10-22Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
#18 | 2020-08-06Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction
#19 | 2020-07-16USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY
#20 | 2020-06-18Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
#21 | 2020-06-11TREATMENT OF DEPRESSIVE DISORDERS
#22 | 2020-06-11Methods and compositions for treatment of epileptic disorders
#23 | 2020-05-07USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS
#24 | 2020-03-26Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
#25 | 2020-01-02Methods of treating developmental disorders and/or seizure disorders with etifoxine
#26 | 2020-01-02METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
#27 | 2019-12-19Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome
#28 | 2019-12-12Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
#29 | 2019-11-21METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#30 | 2019-10-31METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE
#31 | 2019-10-24METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#32 | 2019-10-24USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS
#33 | 2019-10-10Methods and compositions for treatment of epileptic disorders
#34 | 2019-10-03USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF EYE DISORDERS
#35 | 2019-08-22METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#36 | 2019-08-15Methods of treating developmental syndromes with PDE10A inhibitors
#37 | 2019-08-08Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
#38 | 2019-07-18Methods and compositions for treatment of epileptic disorders
#39 | 2019-06-20USE OF hM4Di IN THE TREATMENT OF SEIZURE DISORDERS
#40 | 2019-06-06Use of MIR101 or MIR128 in the treatment of seizure disorders
#41 | 2019-04-25TREATMENT OF DEPRESSIVE DISORDERS
#42 | 2019-04-25Methods of treating developmental disorders with gaboxadol
#43 | 2019-04-18USE OF GABOXADOL IN THE TREATMENT OF TINNITUS
#44 | 2019-04-11METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE
#45 | 2019-03-28Methods of treating developmental disorders and/or seizure disorders with etifoxine
#46 | 2019-03-28METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#47 | 2019-03-21RECOMBINANT ADENO-ASSOCIATED VECTORS
#48 | 2019-03-14Methods of treating behavioral syndromes using pipradrol
#49 | 2019-03-14USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY
#50 | 2019-02-28USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS AND ULTRASOUND IN THE TREATMENT OF SEIZURE DISORDERS
#51 | 2019-02-14Methods of treating developmental disorders with biguanides
#52 | 2019-02-07Use of Gaboxadol in the treatment of diabetes and related conditions
#53 | 2019-01-03TREATMENT OF DEVELOPMENTAL SYNDROMES
#54 | 2018-12-06TREATMENT OF DEVELOPMENTAL DISORDERS WITH IMIDAZOLONE DERIVATIVES
#55 | 2018-12-06Use of gaboxadol in the treatment of tinnitus
#56 | 2018-12-06METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#57 | 2018-11-29METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#58 | 2018-11-29TREATMENT OF DEPRESSIVE DISORDERS
#59 | 2018-10-25Methods for treating aggression associated with Alzheimer's disease
#60 | 2018-10-18Methods of treating developmental encephalopathies
#61 | 2018-08-30Methods of treating seizure disorders
#62 | 2018-08-23METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING CRITICAL CARE TREATMENT
#63 | 2018-08-09Use of gaboxadol in the treatment of tinnitus
#64 | 2018-08-09METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
#65 | 2018-05-31METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL
#66 | 2018-05-24METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE
#67 | 2018-04-12METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#68 | 2018-02-22Methods of treating developmental disorders with biguanides
#69 | 2018-02-15METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#70 | 2018-02-08METHODS OF TREATING BEHAVIORAL SYNDROMES USING PIPRADROL
#71 | 2018-01-18METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
#72 | 2017-12-07Methods of treating Prader-Willi syndrome
#73 | 2017-12-07FORMULATIONS OF GABOXADOL FOR TREATMENT OF ANGELMAN SYNDROME, FRAGILE X SYNDROME AND FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME
#74 | 2017-11-30Methods of treating behavioral syndromes using pipradrol
#75 | 2017-11-09METHODS OF TREATING DEVELOPMENTAL DISORDERS USING GABOXADOL
#76 | 2017-10-19Methods of sedation during critical care treatment
#77 | 2017-09-28METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
#78 | 2017-08-31METHODS OF TREATING DEVELOPMENTAL DISORDERS USING GABOXADOL
#79 | 2017-08-03Methods of treating developmental disorders using pipradrol
#80 | 2017-05-04TREATMENT OF COGNITIVE IMPAIRMENT
#81 | 2017-03-30Methods of increasing tonic inhibition and treating secondary insomnia
#82 | 2017-03-16Methods of treatment Rett syndrome
#83 | 2017-03-09METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL
#84 | 2017-02-16Methods of sedation during critical care treatment
#85 | 2017-01-19METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
#86 | 2017-01-19Methods of treating Dravet syndrome
#87 | 2016-12-01Methods of treating Prader-Willi Syndrome
#88 | 2016-11-03METHODS OF TREATING PRADER-WILLI SYNDROME
#89 | 2016-08-11Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome
#90 | 2016-08-04TOPICAL COMPOUNDS CONTAINING ADIPOSE-DERIVED HORMONES FOR THE REJUVENATION OF SKIN
#91 | 2016-07-26Methods of sedation during critical care treatment
#92 | 2016-05-31Methods of treating developmental disorders using pipradrol
#93 | 2016-02-11Methods of increasing tonic inhibition and treating secondary insomnia
#94 | 2015-12-10METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
#95 | 2015-11-05METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH NEURODEGENERATIVE DISORDERS
1344331 ⎘